ArticleCancer immunology, immunotherapy : CII2021

Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program.

Javier Arranz-Nicolás et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.